An interventional study of Music therapy in Cancer (With or Without Metastasis), sponsored by Institut du Cancer de Montpellier - Val d'Aurelle. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-09.
Sponsored by Institut du Cancer de Montpellier - Val d'Aurelle · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The innovative nature of this project lies in the combination of three types of intervention: tobacco addiction treatment, music therapy and therapeutic education.
Three disciplines that work together.
In this programme, patients play an active role on several levels:
Music therapy could address the three elements mentioned above:
Music therapy could increase the chances of successful cessation. It therefore seems innovative to offer an educational intervention combining the tobacco specialist nurse and the music therapist, which would enable patients to use a musical tool co-developed with the music therapist independently at home. There are no data on the learning and use of such a tool to reinforce self-efficacy in managing smoking cessation. The analysis of the existing literature is poor in terms of music therapy and addiction and virtually non-existent in terms of tobacco addiction.
The objective is to evaluate the feasibility of an intervention combining tobacco addiction treatment and music therapy and its impact on smoking cessation symptoms in patients with cancer who smoke.
10,838 studies on the registry are indexed under Neoplasms; 2,322 are open to participants now.
This study's planned enrollment of 26 is below the median of 60 across 7,716 interventional studies indexed under Neoplasms.
Browse Neoplasms studies →Institut du Cancer de Montpellier - Val d'Aurelle is the lead sponsor of 142 studies on the registry; 46 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Tabacco nurse consultation with music therapy session will be done at day 1 day 7 day 15 day 30 month 2 month 3 and month 6 (end of study)
Other: Music therapy
Music therapy sessions in addition to nursing consultations: creation of a soundtrack to listen to in order to help quit smoking
Proportion of patients who adhered to the supervised sessions, combining follow-up by a tobacco addiction nurse and follow-up in music therapy
The patient is considered compliant if they have participated in 4 or more of the 6 supervised sessions combining tobacco addiction consultations
Time frame: From baseline to month 6
Tobacco use
Number of cigarettes smoked per day and Measurement of exhaled CO and Tobacco dependence scale score: Simplified Fagerström Test
Time frame: at baseline, at month 3, at month 6
Withdrawal symptoms
Scores on the Smoking Cessation Scale
Time frame: at baseline, at month 3, at month 6
The craving
Scores obtained on the French Tobacco Craving Questionnaire
Time frame: at baseline, at month 3, at month 6
Motivation
Scores on the 0-10 Digital Scale assessing motivation
Time frame: at baseline, at month3, at month 6
Confidence
Scores on the EN assessing confidence
Time frame: at baseline, at month 3, at month 6
Sense of personal competence
General Self Efficacy Scale questionnaire
Time frame: at baseline, at month 3, at month 6
Symptoms of anxiety and depression
Anxiety and depression scores on the Hospital Anxiety and Depression Scale
Time frame: at baseline, at month 3, at month 6
Describe adherence to independent listening in music therapy between T2 and T6.
Describe the number of times the patient listened to the audio recording per day, as recorded in a logbook.
Time frame: at baseline, at month 3 and at month 6
Plan to share: Yes
Started Feb 2026 (actual). Primary completion is estimated for Dec 2026, 10 months after the start.
Of 1,993 non-industry interventional studies with no phase under Neoplasms, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 52. This study's planned 10 months is below that.
Counting every sponsor, half of 2,068 studies reached it within 29 months; a quarter within 13 and three quarters within 52.
Neoplasms covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Institut du Cancer de Montpellier - Val d'Aurelle →